Phyllanthus emblica is an euphorbiaceous plant that has long been used in traditional medicines for health promotion, anti-aging and also for treatment of wide ranges of symptoms and diseases. The aim of this study is to investigate the pharmacological activity of the plant branch. Alcohol based extracts of P. emblica branch were prepared in 50 % ethanolic extract by maceration (EPE) and methanolic extract by Soxhlet apparatus (MPE). EPE and MPE contained high total phenolic content and strong antioxidative activity. By HPLC analysis, gallic acid and vanillic acid are the major phenolic compounds of these extracts. Both EPE and MPE inhibited tyrosinase activity stronger than the ethanolic extract of P. emblica fruit (IC50 of 247.37 ± 18.57 and 193.75 ± 44.90 versus 4346.95 ± 166.23 μg/ml). EPE significantly inhibited the mRNA expressions of tyrosinase, and tyrosinase related proteins (TRP-1 and TRP-2) in B16 murine melanoma cells and suppressed the expression of LPS-induced pro-inflammatory genes (COX-2, iNOS, TNF-α, IL-16 and IL-6) in RAW 264.7 murine macrophage cells in a dose-dependent manner. These extracts significantly suppressed the carrageenan-induced paw edema in rats in a dose-dependent manner.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11418-014-0824-1 | DOI Listing |
Transl Behav Med
January 2025
School of Medicine and Public Health, The University of Newcastle, Newcastle, University Drive, Callaghan, 2308 New South Wales, Australia.
This review assessed the effect of strategies designed to sustain the delivery of evidenced based interventions (EBIs) which target behavioural risk factors linked to leading causes of chronic disease in clinical and community settings. Seven electronic databases were searched for randomised controlled studies published from earliest record to November 2022. Studies were included if they tested a strategy to sustain the delivery of an EBI within clinical or community settings.
View Article and Find Full Text PDFPostgrad Med J
January 2025
Department of Gastroenterology, Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Shinan District, Qingdao 266075, China.
Background: Abdominal pain is one of the most prominent symptoms in patients with chronic pancreatitis (CP) and can manifest intermittently or persistently. The mechanism of pain is not yet clear, and no effective treatment is currently available. This study aimed to explore the risk factors for pain in patients with CP, which may provide new insights for developing effective pain control modalities.
View Article and Find Full Text PDFTrauma Violence Abuse
January 2025
Rollins School of Public Health, Emory University, Atlanta, GA, USA.
We present the first systematic review and meta-analysis of the literature on intimate partner violence (IPV) among LGBTQ+ adults in Latin America and the Caribbean (LAC). Of 1,234 articles, 22 met inclusion criteria, and data were extracted for 4 key research areas: prevalence, measurement, risk and protective factors, and interventions. LGBTQ+ adults in LAC experience IPV at similar or higher rates than those documented among cisgender heterosexuals, with estimates ranging from 0.
View Article and Find Full Text PDFJMIR Public Health Surveill
January 2025
School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 5/F, Academic Building, 3 Sassoon Road, Pok Fu Lam, Hong Kong, China (Hong Kong), 852 39176972.
Background: Women and sexual minority individuals have been found to be at higher risk for experiencing poor sleep health compared to their counterparts. However, research on the sleep health of sexual minority women (SMW) is lacking in China.
Objective: This study aimed to examine sleep quality and social support for Chinese women with varied sexual identities, and then investigate the in-depth relationships between sexual identity and sleep.
Front Pharmacol
January 2025
School of Pharmacy, Jiangsu University, Zhenjiang, China.
Introduction: The L. (PVL) and Hand.-Mazz.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!